World-Wide Efficacy of Bone Marrow Derived Mesenchymal Stromal Cells in Preclinical Ischemic Stroke Models: Systematic Review and Meta-Analysis
Background: Following extensive, positive results in pre-clinical experiments, Bone Marrow Derived-Mesenchymal Stromal Cells (BM-MSCs) are now being tested as a novel therapy for ischemic stroke in ongoing clinical trials. However, multiple critical questions relating to their translational applicat...
Main Authors: | Nikunj Satani, Chunyan Cai, Kaavya Giridhar, Daryl McGhiey, Sarah George, Kaushik Parsha, Duyen M. Nghiem, Krystal S. Valenzuela, Jenny Riecke, Farhaan S. Vahidy, Sean I. Savitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00405/full |
Similar Items
-
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro
by: Nikunj Satani, et al.
Published: (2021-04-01) -
Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes
by: Nikunj Satani, et al.
Published: (2020-01-01) -
Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model
by: Bing Yang, et al.
Published: (2016-01-01) -
Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
by: Behnam Sadeghi, et al.
Published: (2019-11-01) -
Mesenchymal stromal cells for articular cartilage repair: preclinical studies
by: P Fernández-Pernas, et al.
Published: (2020-08-01)